IRIS
LLEO DE NALDA, Ana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.167
AS - Asia 2.828
EU - Europa 1.410
SA - Sud America 834
AF - Africa 224
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 11.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.058
SG - Singapore 1.601
BR - Brasile 725
CN - Cina 647
FI - Finlandia 285
IT - Italia 246
IE - Irlanda 205
NG - Nigeria 170
DE - Germania 141
VN - Vietnam 136
FR - Francia 109
HK - Hong Kong 101
SE - Svezia 90
GB - Regno Unito 84
NL - Olanda 69
CA - Canada 55
IN - India 51
AE - Emirati Arabi Uniti 49
AR - Argentina 46
TR - Turchia 43
RU - Federazione Russa 36
MX - Messico 32
BE - Belgio 27
IQ - Iraq 27
BD - Bangladesh 24
ZA - Sudafrica 21
IL - Israele 20
MK - Macedonia 20
CZ - Repubblica Ceca 16
EC - Ecuador 16
ID - Indonesia 16
JP - Giappone 15
PK - Pakistan 15
PL - Polonia 15
UA - Ucraina 15
ES - Italia 12
PY - Paraguay 11
UZ - Uzbekistan 11
CL - Cile 10
MA - Marocco 10
SA - Arabia Saudita 10
KZ - Kazakistan 8
PH - Filippine 8
CO - Colombia 7
KR - Corea 7
RO - Romania 7
AT - Austria 6
AU - Australia 6
ET - Etiopia 6
JO - Giordania 6
VE - Venezuela 6
AZ - Azerbaigian 5
IR - Iran 5
KE - Kenya 5
PE - Perù 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BB - Barbados 4
EG - Egitto 4
GR - Grecia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
DO - Repubblica Dominicana 3
EU - Europa 3
JM - Giamaica 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TH - Thailandia 2
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
Totale 11.476
Salva come PNG Salva come JPEG
Città #
Chandler 957
Wilmington 825
Singapore 533
Dallas 438
The Dalles 397
Shanghai 355
San Mateo 313
Helsinki 283
Ann Arbor 266
Ashburn 234
New York 208
Dublin 205
Boardman 189
Beijing 174
Benin City 167
Lawrence 155
Princeton 155
Leawood 141
Hong Kong 100
Paris 92
Milan 91
Fairfield 70
Woodbridge 70
São Paulo 64
Ho Chi Minh City 53
Amsterdam 51
Los Angeles 49
London 44
Seattle 42
Toronto 32
Phoenix 30
Brussels 27
Naples 27
Hanoi 26
Council Bluffs 18
San Diego 18
Santa Clara 18
Pune 17
Redwood City 17
Abbiategrasso 16
Munich 16
Rio de Janeiro 16
Rome 16
Kocaeli 15
Belo Horizonte 14
Brasília 14
Brooklyn 14
Stockholm 14
Baghdad 13
Boston 13
Norwalk 13
Tokyo 13
Columbus 12
Atlanta 11
Brno 11
Porto Alegre 11
Tashkent 11
Warsaw 11
Campinas 10
Chennai 10
Da Nang 10
Guarulhos 10
Guayaquil 10
Johannesburg 10
Mexico City 10
San Francisco 10
Buenos Aires 9
Dhaka 9
Falkenstein 9
Mauá 9
Skopje 9
Ankara 8
Assago 8
Chicago 8
Frankfurt am Main 8
Haiphong 8
Montreal 8
Salvador 8
Duque de Caxias 7
Istanbul 7
Nova Iguaçu 7
Amman 6
Charlotte 6
Clearwater 6
Curitiba 6
Denver 6
Hangzhou 6
Moscow 6
Newark 6
Recife 6
Addis Ababa 5
Asunción 5
Bitola 5
Cuiabá 5
Des Moines 5
Hanover 5
Houston 5
Jundiaí 5
Madrid 5
Maringá 5
Totale 7.511
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 182
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 109
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 104
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 104
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 99
Innate Immunity and Primary Biliary Cirrhosis 94
B cell depletion therapy exacerbates murine primary biliary cirrhosis 94
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 94
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 93
Apotopes and the biliary specificity of primary biliary cirrhosis 93
COVID-19 and liver cancer clinical trials: not everything is lost 92
Autophagy: highlighting a novel player in the autoimmunity scenario 92
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 88
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 88
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 88
Genetic associations in Italian primary sclerosing cholangitis : heterogeneity across Europe defines a critical role for HLA-C 87
The consequences of apoptosis in autoimmunity 83
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 83
Interferon α and its contribution to autoimmunity 82
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 82
High mortality in COVID-19 patients with mild respiratory disease 81
Definition of human autoimmunity - autoantibodies versus autoimmune disease 79
The X chromosome and immune associated genes 79
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 79
Is autoimmunity a matter of sex? 79
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 78
Advances in pharmacotherapy for primary biliary cirrhosis 78
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 78
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 78
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 78
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 77
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 77
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 77
Benign liver tumors: Diagnostics and treatment 77
Autoimmunity and Turner's syndrome 77
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 76
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 75
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 75
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization 75
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 74
The risk of Liver Cancer in Autoimmune Liver Diseases 74
Making sense of Autoantibodies in Cholestatic Liver Diseases 73
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 73
Mapping the human genetic architecture of COVID-19 73
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 72
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 72
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 71
Role of liver biopsy in hepatocellular carcinoma 71
Safety of vedolizumab in liver transplant recipients: A systematic review 71
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 70
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 70
Changes in the Epidemiology of Primary Biliary Cholangitis 69
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 68
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 68
Etiopathogenesis of primary biliary cirrhosis 68
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 67
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 67
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 67
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 67
Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis - an International Follow-up Study 67
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 66
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 66
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 66
The immunological potential of galectin-1 and 3 66
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 66
Antimitochondrial Antibodies: from Bench to Bedside 66
Y chromosome loss in male patients with primary biliary cirrhosis 65
Mediterranean diet and NAFLD: What we know and questions that still need to be answered 65
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 65
Evolving trends in female to male incidence and male mortality of primary biliary cholangitis 65
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 65
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment 65
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 65
Primary biliary cholangitis: a comprehensive overview. 64
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 64
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications 64
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 63
Genetics and epigenetics of primary biliary cirrhosis 63
Comparative analysis of portal cell infiltrates in AMA positive versus AMA negative PBC 63
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 63
Hepatotoxicity of immune check point inhibitors: Approach and management 63
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 63
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 62
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 62
Primary biliary cholangitis 62
Letter to the Editor: might denosumab fit in PBC treatment? 61
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 61
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 61
Interpreting serological tests in diagnosing autoimmune liver diseases 60
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 60
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 60
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells 59
Coronary flow reserve is an innovative tool for the early detection of cardiovascular dysfunction in primary biliary cholangitis patients. 59
Common Variable Immunodeficiency and Liver Involvement 59
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 59
Is there a real survival benefit of surveillance for hepatocellular carcinoma in cirrhotic patients? 58
Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases 58
What is an autoantibody? 58
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 58
Geoepidemiology, gender and autoimmune disease 57
Totale 7.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.459 0 0 0 0 0 512 214 94 294 177 5 163
2021/2022833 30 10 15 178 8 11 22 109 89 92 201 68
2022/20232.567 349 128 244 319 234 221 13 187 459 205 162 46
2023/20241.616 120 146 347 73 46 220 118 99 34 32 133 248
2024/20252.514 55 51 22 60 61 317 224 254 349 566 275 280
2025/20262.613 900 382 499 592 196 44 0 0 0 0 0 0
Totale 11.683